# US 2012/0252903 A1 · Cholesterol control agent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252903 A1
- Document ID: US20120252903A1
- Status: Published application
- Kind: A1
- Application number: 13/523,086
- Filed: 2012-06-14
- Published: 2012-10-04
- Earliest claimed: 2007-07-04
- Inventors: Vladislav Nikolaevich Laskavy; Aleksandr Nikolaevich Shokhin; Sergei Ivanovich Ivanenko
- Web page: https://patentgrep.com/patent/US20120252903A1

## CPC

- A61K 31/115: Formaldehyde
- A61K 9/2009: {Inorganic compounds}
- A61K 9/2018: {Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates}
- A61P 3/06: Antihyperlipidemics
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

There is proposed a method for using a preparation for lowering the cholesterol level of a patient. In preferred embodiments, the preparation essentially consists of an active substance being an aqueous solution of formaldehyde with a concentration of 36.5-40%, the active substance constitutes 2-6 weight units, and an additive being an isotonic solution of sodium chloride with a concentration of 0.85-0.95%, the additive constitutes from 998 to 994 weight units accordingly, to make the total of 1000 weight units. The method includes administering the preparation to the patient in the form of intramuscular injections with a predetermined dose at a predetermined time interval, thereby lowering the cholesterol level of the patient. It is preferable to choose the predetermined time interval from the group consisting of 7, 21, 30, and 60 days. It is also preferable to choose the predetermined dose in the amount of 5 mL.

## Claims

### Claim 1

A method for using a preparation for lowering the cholesterol level of a patient, said preparation consists essentially of an active substance in the form of an aqueous solution of formaldehyde with a concentration of 36.5-40%, said active substance constitutes from 2 to 6 weight units, and an additive in the form of an isotonic solution of sodium chloride with a concentration of 0.85-0.95%, said additive constitutes from 998 to 994 weight units accordingly, to make the total of 1000 weight units;
said method comprises a step of: administering said preparation to the patient in the form of intramuscular injections with a predetermined dose at a predetermined time interval, thereby lowering the cholesterol level of said patient.

### Claim 2 (depends on 1)

The method of claim 1, wherein said predetermined time interval is selected from the group consisting of 7, 21, 30, and 60-day intervals.

### Claim 3 (depends on 2)

The method of claim 2, wherein said predetermined dose constitutes 5 mL.
